Market Update: Merck & Co Inc (NYSE:MRK) – Merck Marks 30-Year Milestone in Commitment to Innovation and Care in HIV/AIDS

[Business Wire] – Merck , known as MSD outside the United States and Canada, announced today that the company’s commitment to HIV and AIDS, which started with a research and development program initiated . . . → Read More: Market Update: Merck & Co Inc (NYSE:MRK) – Merck Marks 30-Year Milestone in Commitment to Innovation and Care in HIV/AIDS Similar Articles: Company Update (NYSE:MRK): Merck to Hold Second-Quarter 2015 Sales and Earnings Conference Call on July 28 Company Update: Merck & Co Inc (NYSE:MRK) – Merck Reaffirms Continued Commitment to Developing Innovative Medicines for the Treatment of Infectious Diseases at 25th Annual ECCMID Congress Stock Update (NYSE:MRK): Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone